Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PCM Trials is a community-based, mobile service provider for the clinical research industry. According to the website, it is being integrated with EmVenio Research and Clinical Trial Service into EmVenio Clinical Research. It is not a typical general-purpose SaaS product; instead, it provides decentralized/hybrid clinical trial support for pharmaceutical companies, sponsors, CROs, and research sites. Its core goal is to bring clinical trials to patients in settings such as homes, schools, offices, and long-term care facilities.
Its main capabilities include a global network of community research sites, mobile research services, Certified Mobile Research Nurses/Clinicians, operational support, and eSource electronic source data capture. Mobile clinical staff can perform tasks such as drug administration, blood draws, sample collection, clinical assessments, AE monitoring, device operation, and patient education. The operations team coordinates with sites, pharmacies, laboratories, vendors, and sponsors, while also supporting IMP delivery, storage, inventory, returns, and document quality checks. Its eSource solution uses cellular-enabled tablets for real-time data entry, supports remote monitoring, PI oversight, and audit trails, and states compliance with 21 CFR Part 11, GDPR, HIPAA, GCP, and SOP requirements.
The website does not disclose standard plans, pricing, or subscription models. Project evaluation and quoting are mainly handled through Submit RFP, email, phone, or scheduled one-on-one meetings. This means procurement is closer to an enterprise-level clinical research outsourcing service than a ready-to-use software subscription.
Its strengths lie in deep vertical specialization and strong clinical operational capabilities. Through community sites and in-home visits, it can lower the barriers to patient participation, making it especially valuable for diversity recruitment, rare disease research, and long-term follow-up. Its compliance statements are also relatively comprehensive. The drawbacks are that publicly available information lacks details on APIs, third-party system integrations, permission models, deployment architecture, SLAs, and pricing transparency. For teams looking to purchase a pure software platform, the product boundaries may not be clear enough.
It is suitable for sponsors, CROs, and large research institutions that need to conduct decentralized or hybrid clinical trials, improve recruitment and retention, and reach underrepresented populations. It is not suitable for users looking for a general project management tool, CRM, or self-service clinical trial SaaS.
The text does not provide information on access from mainland China, service coverage, or local compliance. Its access status is therefore unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pcmtrials.com official site.
pcmtrials.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach pcmtrials.com directly.